Next Generation Sequencing Analysis of Platinum Refractory Advanced Germ Cell Tumor Sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R Inhibitor in a Phase II Trial

Journal of Hematology and Oncology - United Kingdom
doi 10.1186/s13045-014-0052-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

A Phase 2 Trial of Sunitinib in Patients With Advanced Non–clear Cell Renal Cell Carcinoma

European Urology
Urology
2012English

A Phase II Trial of Sunitinib in Patients With Renal Cell Cancer and Untreated Brain Metastases

Clinical Genitourinary Cancer
OncologyUrology
2014English

Phase II Trial of Sunitinib Maintenance Therapy After Platinum-Based Chemotherapy in Patients With Extensive-Stage Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2011English

Phase II Study of Sorafenib in Patients With Sunitinib-Refractory Metastatic Renal Cell Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

EMBRACE Workshop “NEXT GENERATION SEQUENCING II”

EMBnet.journal
2010English

A Phase II Trial of Tremelimumab (CP-675,206) in Patients With Advanced Refractory or Relapsed Melanoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2008English

A Phase II Trial of Docetaxel and Ifosfamide for Patients With Platinum-Resistant or Refractory Non-Small Cell Lung Cancer in a Salvage Setting

Cancer Research and Treatment
Cancer ResearchOncology
2004English

A Phase II Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Biliary Tract Cancers

Clinical Colorectal Cancer
OncologyGastroenterology
2014English

Hybridization Capture-Based Next Generation Sequencing Reliably Detects FLT3 Mutations and Classifies FLT3-internal Tandem Duplication Allelic Ratio in Acute Myeloid Leukemia: A Comparative Study to Standard Fragment Analysis

Modern Pathology
Forensic MedicinePathology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy